Cyclerion Therapeutics,Inc. (CYCN)
NASDAQ:CYCN
US Market
Holding CYCN?
Track your performance easily

Cyclerion Therapeutics (CYCN) Income Statement

159 Followers

Cyclerion Therapeutics Income Statement

Last quarter (Q ), Cyclerion Therapeutics's total revenue was $―, a decrease of ― from the same quarter last year. In Q, Cyclerion Therapeutics's net income was $-1.32M. See Cyclerion Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
--$ 297.00K$ 3.94M$ 2.30M$ 4.51M
Cost of Revenue
------
Gross Profit
--$ 297.00K$ 3.94M$ 2.30M$ 4.51M
Operating Expense
$ 1.36M$ 9.65M$ 18.84M$ 59.14M$ 83.56M$ -129.54M
Operating Income
$ -4.67M$ -12.95M$ -18.54M$ -55.20M$ -81.27M$ -125.04M
Net Non Operating Interest Income Expense
$ -358.00K$ -358.00K$ -294.00K---
Other Income Expense
$ -3.29M$ -3.30M$ -294.00K$ -2.70M$ -588.00K$ -2.03M
Pretax Income
$ -4.32M$ -12.59M$ -18.25M$ -51.61M$ -84.02M$ -123.01M
Tax Provision
$ -5.00K$ -5.00K$ -2.69M$ -3.63M$ -5.62M$ -9.80M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ 3.01M$ -5.26M$ -44.08M$ -51.65M$ -77.80M$ -123.01M
Basic EPS
$ 1.63$ -2.25$ -20.20$ -26.40$ -51.20-
Diluted EPS
$ 1.63$ -2.25$ -20.20$ -26.40$ -51.20$ -89.80
Basic Average Shares
$ 12.07M$ 2.34M$ 2.17M$ 1.96M$ 1.52M$ 1.37K
Diluted Average Shares
$ 12.07M$ 2.34M$ 2.17M-$ 1.52M$ 1.37M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 4.67M$ 9.65M$ 18.84M$ 59.14M$ 83.56M$ -129.54M
Net Income From Continuing And Discontinued Operation
$ 3.01M$ -5.26M$ -44.08M$ -51.65M$ -77.80M$ -123.01M
Normalized Income
$ -2.16M$ -9.86M-$ -54.36M--
Interest Expense
------
EBIT
$ -7.37M$ -9.65M$ -18.54M$ -54.31M$ -82.93M$ -123.01M
EBITDA
$ -7.37M$ -9.65M$ -18.48M$ -53.84M$ -80.64M$ -120.31M
Currency in USD

Cyclerion Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis